We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App





bioMérieux Showcases State-Of-The-Art Data and Connectivity Tools

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: The VITEK® REVEAL™ rapid Antimicrobial Susceptibility Testing helps better manage bloodstream infections (Photo courtesy of bioMérieux)
Image: The VITEK® REVEAL™ rapid Antimicrobial Susceptibility Testing helps better manage bloodstream infections (Photo courtesy of bioMérieux)

bioMérieux (Marcy l'Etoile, France) is showcasing its latest innovations at Medlab Middle East 2025 that are designed to support the timely delivery of results for impacting patient therapy.

Stopping the spread of resistant organisms means ensuring patients get the right dose at the right time. bioMérieux offers a one-stop-shop to provide critical diagnostic results the length of the antimicrobial resistance (AMR) patient pathway from therapy initiation to optimization to discontinuation. At the 2025 edition of Medlab Middle East, bioMérieux is exhibiting the VITEK® MS PRIME new-generation mass spectrometry microbial identification system. VITEK® MS PRIME combines microbiology expertise with innovation, taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. Alongside, bioMérieux is presenting the newest addition to its Sepsis Solution, VITEK® REVEAL™ which offers rapid antimicrobial susceptibility testing (AST) results to effectively and efficiently manage bloodstream infections

bioMérieux is also showcasing its stackable benchtop automated immunoassay solution, VIDAS® KUBE™ that is designed to preserve everything labs appreciate about the VIDAS® Solution combined with advanced technology. VIDAS® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence. VIDAS® KUBE™ adaptable automation helps labs be more productive, more accurate, and more innovative – all in one simplified platform. Scaling with ease, VIDAS® KUBE™ is a simple and reliable addition to evolving labs, offering smart innovations that are both time- and cost-saving.

bioMérieux is contributing to the fight against AMR by expanding syndromic testing technology outside traditional clinical laboratories to the point-of-care settings to provide patients with fast answers, while giving clinicians the information they need to make timely, targeted treatment decisions. Among its solutions are BIOFIRE® FIREWORKS™ and BIOFIRE® SPOTFIRE® Respiratory Panels for providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, workflow management, and more. Also featuring at the event is the BIOFIRE® SPOTFIRE® System, the latest advancement in molecular infectious disease diagnostics from bioMérieux, with all of its expertise and cutting-edge FILMARRAY® technology at the heart of the system design.

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.